Companies developing antibiotics to get financial and technical support from more than 20 firms contributing to new AMR Action Fund. Initiative is also pushing for reimbursement reform and other policies to support commercial marketing.
Big pharma companies are putting their muscle behind a new initiative to help smaller entities get antibiotics through the pipeline. But they acknowledge the effort will be futile without reimbursement reform and other measures to help companies survive once they get a product on the market.
CEOs from Eli Lilly and Company, Merck & Co., and Pfizer Inc. were part of a 9...
Recent and upcoming US FDA advisory committee meetings and a summary of the topics covered.
The UK’s research-based pharma industry and medical research charities have set out clear action points to drive greater diversity and inclusion in clinical trials.
Blenrep, GSK’s multiple myeloma therapy, faced a major setback when it was withdrawn from the market in 2022. The drug has since made a return as a second-line therapy, and is on track to being reimbursed in England.
